Evidence map›Paper›PMID 34659422›Full record

ArticleInternational journal of pediatrics2021

Prevalence and Presentation of Paediatric Coronavirus Disease 2019 in Lagos, Nigeria.

Abideen Salako, Oluwatosin Odubela, Tomilola Musari-Martins, Priscilla Ezemelue, Titilola Gbaja-Biamila, Babasola Opaneye, Ayorinde James, Osaga Oforomeh, Kazeem Osuolale, Adesola Musa and 6 more

Abstract read
In one paragraph

Article in International journal of pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Burden of SARS-CoV-2 and protection from symptomatic second infection in children.medRxiv : the preprint server for health sciences · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Abideen SalakoNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-3018-3712
Oluwatosin OdubelaNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-4432-9137
Tomilola Musari-MartinsNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0001-9961-1300
Priscilla EzemelueNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-0382-6188
Titilola Gbaja-BiamilaNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0003-2958-2924
Babasola OpaneyeNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.
Ayorinde JamesNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0003-3693-1096
Osaga OforomehNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-3986-8961
Kazeem OsuolaleNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-4759-2432
Adesola MusaNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.
Emelda ChukwuNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-3110-1678
Nurudeen RahmanNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0001-7521-0385
Agatha DavidNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-7773-6206
Rosemary AuduNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-0330-5219
Oliver EzechiNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0003-0688-3898
Babatunde SalakoNigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-0963-7302

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of this study was to describe the prevalence and clinical features of coronavirus disease 2019 (COVID-19) among children (≤18 years) evaluated for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection at a testing centre in Lagos, Nigeria.

resultsA total of 307 children (≤18 years) were evaluated in this review. The prevalence of SARS-CoV-2 infection among the paediatric population was 16.3%. The median age (interquartile range (IQR)) was 9 (4-14) years. Common symptoms reported by the positive cases were fever (40.0%), cough (32.9%), sore throat (17.1%), and runny nose (15.7%). The majority of the positive cases had mild symptoms. Fever and sore throat were associated with the positive cases.

conclusionFever and sore throat were associated with SARS-CoV-2 infection among our cohort which buttresses the need for a high level of suspicion and clinical acumen in the management of common febrile diseases in paediatric settings.

Identifiers

PMID34659422
PMCPMC8514970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.